N-[(5-bromo-1-methyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide
Structure Info
- Chemspace ID
- CSSB21332165043 (In-Stock Building Blocks)
- IUPAC Name
- N-[(5-bromo-1-methyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide
- Mol formula
- C12H12BrN3O
- Mol weight
- 294 Da
- Catalog Number(s)
- BBLS21332165043, EN300-54539811, bbls21332165043
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.03
- Heavy atoms count
- 17
- Rotatable bond count
- 3
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.166
- Polar surface area (Å)
- 47
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(5-bromo-1-methyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide (C12H12BrN3O) - CSSB21332165043](/st/structure/200/90655756252cccbb1508eadbeba00b41/CN1C%2528CNC%2528%253DO%2529C%253DC%2529%253DNC2%253DC1C%253DCC%2528Br%2529%253DC2.png "C12H12BrN3O")
- Zoom the structure
- CSSB21332165043
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 743.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 779.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 814.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 849.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 884.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,735.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,566.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 3,807.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[(5-chloro-1-methyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide - CSSB01997775804](/st/structure/200/d7f683fe2d25913c04e2116c86e230c8/C%253DCC%2528%253DO%2529NCC1%253DNC2%253DCC%2528Cl%2529%253DCC%253DC2N1C.png)
![Chemical structure of N-[(1,5-dimethyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide - CSSB01995170500](/st/structure/200/484abc85a689425b409baabfef13905e/C%253DCC%2528%253DO%2529NCC1%253DNC2%253DCC%2528C%2529%253DCC%253DC2N1C.png)
![Chemical structure of N-[(5-fluoro-1-methyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide - CSSB01995408068](/st/structure/200/a66e116257788f1d1046d7f9f19ae69b/C%253DCC%2528%253DO%2529NCC1%253DNC2%253DCC%2528F%2529%253DCC%253DC2N1C.png)
![Chemical structure of N-[(1-methyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide - CSSB00038111745](/st/structure/200/b9819e39880077b820102da197d31364/CN1C%2528CNC%2528%253DO%2529C%253DC%2529%253DNC2%253DCC%253DCC%253DC12.png)
![Chemical structure of N-[(5-methoxy-1-methyl-1H-1,3-benzodiazol-2-yl)methyl]prop-2-enamide - CSSB00152975882](/st/structure/200/b689cdc146200d6120288144cb31d341/COC1%253DCC%253DC2N%2528C%2529C%2528CNC%2528%253DO%2529C%253DC%2529%253DNC2%253DC1.png)
![Chemical structure of N-[(5-bromo-1-methyl-1H-1,3-benzodiazol-2-yl)methyl]-2-chloroacetamide - CSSB03540367970](/st/structure/200/7768a7026bded9cf6615041d6aed36c7/CN1C%2528CNC%2528%253DO%2529CCl%2529%253DNC2%253DCC%2528Br%2529%253DCC%253DC12.png)
![Chemical structure of N-[(5-bromo-1-methyl-1H-1,3-benzodiazol-2-yl)methyl]ethene-1-sulfonamide - CSSB21332108217](/st/structure/200/7eb47cff4657f77d496167281efc3e09/CN1C%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529%253DNC2%253DC1C%253DCC%2528Br%2529%253DC2.png)
